View Older Stories View More Recent Stories
-
Q BioMed Inc. Prices $5.5 Million Public Offering
-
CymaBay Therapeutics (CBAY) Prices 11.6M Shares at $10.80
-
CymaBay Announces Pricing of Public Offering of Common Stock
-
Silicon Labs (SLAB) PT Raised to $110 at Roth Capital; Reiterates Buy
-
Eyenovia Announces Closing of $27.3 Million Initial Public Offering
-
Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
-
Roth Capital Starts CynergisTek (CTEK) at Buy
-
Evolution Petroleum Reports Quarterly Update on Delhi and Announces Fiscal Second Quarter 2018 Earnings Release Date
-
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017
-
Stemline Therapeutics Closes $59.6 Million Public Offering of Common Stock
-
PlayAGS (AGS) IPO Opens Up 6%
-
PlayAGS Inc. (AGS) Prices 10.25M Share IPO at $16/Sh
-
AGS Prices Initial Public Offering
-
Eyenovia (EYEN) IPO Opens Flat
-
Las Vegas Sands (LVS) PT Raised to $85 at Roth Capital
-
Albireo Pharma (ALBO) Prices 1.97M Common Stock Offering at $33/Share
-
Albireo Prices $65.0 Million Public Offering of Common Stock
-
Roth Capital Assumes CymaBay Therapeutic (CBAY) at Buy
-
Eyenovia Inc. (EYEN) Prices 2.73M Share IPO at $10/Sh
-
Eyenovia Announces Pricing of Initial Public Offering
-
Albireo Pharma (ALBO) to Offer Common Stock
-
Albireo Announces Proposed Public Offering of Common Stock
-
U.S. Geothermal Inc. Enters Into Definitive Agreement to Be Acquired by Ormat Technologies Inc. for $5.45 in Cash Per Share
-
Stemline Therapeutics (STML) Prices 3.7M Share Offering at $14/Sh
-
Stemline Therapeutics Prices $51.8 Million Public Offering of Common Stock
-
GT Biopharma Announces $7.1 Million Convertible Debt Financing
-
GT Biopharma Announces $7.1 Million Convertible Debt Financing
-
GT Biopharma Announces $7.1 Million Convertible Debt Financing
-
Cooper-Standard Holdings Inc. (CPS) PT Raised to $150 at Roth Capital
-
Roth Capital Downgrades Cree (CREE) to Neutral
-
RSP Permian, Inc. (RSPP) PT Raised to $50.50 at Roth Capital Following Model Adjustment to Reflect Higher 2018 WTI Prices
-
Diamondback Energy (FANG) PT Raised to $145 at Roth Capital
-
Hydrogenics (HYGS) PT Raised to $14 at Roth Capital; '$7.8M Chinese Bus Order Lifts 2018 Outlook'
-
QuickLogic (QUIK) PT Raised to $2.50 at Roth Capital
-
PlacementTracker Publishes 2017 PIPE and Private Placement Markets League Tables
-
The Offering Statement Relating to iPic® Entertainment's Initial Public Offering is Now Qualified
-
Roth Capital Starts iPass Inc. (IPAS) at Buy, 'Global Wifi Leader...to Mobile SaaS, Software and AI'
-
Roth Capital Starts MobileIron (MOBL) at Buy, 'EMM Leaders Poised for Reaccelerating Growth'
-
Roth Capital Starts MobileIron (MOBL) at Buy, 'EMM Leaders Poised for Reaccelerating Growth'
-
Roth Capital Starts Boingo Wireless (WIFI) at Buy
-
Roth Capital Starts eGain Corporation (EGAN) at Buy
-
Ring Energy, Inc. (REI) PT Raised to $22 at Roth Capital
-
Roth Capital Starts Sierra Metals Inc. (SMTS) at Buy
-
Digital Turbine (APPS): PT Jumps To $2.50 After CEO Meeting at Roth
-
AGS Commences Initial Public Offering
-
FuelCell Energy (FCEL): F4Q17 Strong on Korean Project - Roth
-
Quantenna to Present at Upcoming Investor Conferences
-
ADOMANI Completes $11 Million Secondary Equity Offering; Boustead Securities Underwrites and Places First Form S-1 Fundraise for a NASDAQ-Listed Regulation A+ IPO Issuer
-
ADOMANI Completes $11 Million Secondary Equity Offering; Boustead Securities Underwrites and Places First Form S-1 Fundraise for a NASDAQ-Listed Regulation A+ IPO Issuer
-
ADOMANI, Inc. Announces Closing of Public Offering of Units

